Summary:
Stanford University is conducting a research study looking at the effect of an insulin-sensitizing drug on treatment for depression.
Qualified Participants Must:
• Have non-remitted depressive symptoms (either unipolar or bipolar depression are OK).
•
Be between 20 and 65 years of age
•
Not currently have a diagnosed with diabetes.
Qualified Participants May Receive:
Study participants receive assessment of their cognitive and metabolic functioning and are compensated for their time.